Loading chat...
NY A07311
Bill
Status
3/25/2025
Primary Sponsor
Gary Pretlow
Click for details
AI Summary
-
Mandates coverage for human leukocyte antigen (HLA) testing, also called histocompatible locus antigen testing, for A, B, and DR antigens used in tissue typing for bone marrow matching
-
Applies to individual policies providing hospital, surgical, medical care, laboratory tests, or diagnostic X-ray services
-
Extends the coverage requirement to group and blanket health insurance policies delivered or issued in New York
-
Requires medical expense indemnity corporations, hospital service corporations, and health service corporations to include HLA testing coverage
-
Exempts policies covering employees in multiple states or those with benefit structures subject to multi-state collective bargaining agreements
-
Takes effect January 1 following enactment, applying to all policies issued, renewed, modified, or amended after that date
Legislative Description
Requires certain health insurance policies and contracts to provide coverage for human leukocyte antigen testing, also referred to as histocompatible locus antigen testing, for A, B, and DR antigens, for utilization in tissue typing for bone marrow testing.
Last Action
referred to insurance
1/7/2026